Fransiscus E. Utama, Ph.D.
Affiliations: | Purdue University, West Lafayette, IN, United States |
Area:
Cancer, Immunology, TranscriptionGoogle:
"Fransiscus Utama"Mean distance: 17.46 (cluster 11) | S | N | B | C | P |
Parents
Sign in to add mentorElizabeth Jane Taparowsky | grad student | 2003 | Purdue | |
(Characterization of OS -9, a novel Myc -interacting protein.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Yang N, Liu C, Peck AR, et al. (2013) Prolactin-Stat5 signaling in breast cancer is potently disrupted by acidosis within the tumor microenvironment. Breast Cancer Research : Bcr. 15: R73 |
Rui H, Zhang J, Yanac A, et al. (2013) Abstract P5-04-05: Preclinical modeling of luminal breast cancer: Recapitulating progression to lethal and tamoxifen-resistant lung metastases in novel patient-derived xenotransplant models in prolactin-humanized mice Cancer Research. 73 |
Peck A, Yang N, Yanac A, et al. (2013) Abstract P1-06-10: Characterization of novel activated human mammary fibroblast lines and their protumorigenic effect on human breast cancer xenotransplants in mice Cancer Research. 73 |
Yang N, Utama FE, Yanac AF, et al. (2011) Xenotransplantation of surgical specimens of human breast cancer directly into genetically engineered prolactin-humanized immunodeficient mice. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 76 |
Johnson KJ, Peck AR, Liu C, et al. (2010) PTP1B suppresses prolactin activation of Stat5 in breast cancer cells. The American Journal of Pathology. 177: 2971-83 |
Tran TH, Utama FE, Lin J, et al. (2010) Prolactin inhibits BCL6 expression in breast cancer through a Stat5a-dependent mechanism. Cancer Research. 70: 1711-21 |
Utama FE, Tran TH, Ryder A, et al. (2009) Insensitivity of human prolactin receptors to nonhuman prolactins: relevance for experimental modeling of prolactin receptor-expressing human cells. Endocrinology. 150: 1782-90 |
Wang Y, Dean JL, Millar EK, et al. (2008) Cyclin D1b is aberrantly regulated in response to therapeutic challenge and promotes resistance to estrogen antagonists. Cancer Research. 68: 5628-38 |
Witkiewicz A, Ryder A, Neilson LM, et al. (2008) Transcription factors Stat5a and Stat5b: Favorable prognostic markers in breast cancer Journal of Clinical Oncology. 26: 22071-22071 |
Dalmizrak O, Wu A, Chen J, et al. (2007) Insulin receptor substrate-1 regulates the transformed phenotype of BT-20 human mammary cancer cells. Cancer Research. 67: 2124-30 |